Guidelines on engaging with regulators
Many IMI projects are developing tools and methods with a potential regulatory impact, such as tests and measures to evaluate medicines safety or efficacy, or alternative clinical trial designs. For this reason, we encourage all projects to seek regulatory engagement as early as ...